A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
Clinical trial NCT04600817 · UNKNOWN
Trial details
- NCT number
- NCT04600817
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-31
- Primary completion
- 2024-12-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.